Overvaluation Will Crumble Under Intensifying Regulatory And Cost Pressures
AN
AnalystConsensusTarget
Not Invested
Consensus Narrative from 5 Analysts
Published
10 Aug 25
Updated
10 Aug 25
AnalystConsensusTarget's Fair Value
US$74.60
5.8% undervalued intrinsic discount10 Aug
US$70.24
1Y
n/a7D
29.7%